WilmerHale has represented Dyne Therapeutics, Inc. on the transaction.Dyne Therapeutics, Inc. has completed a senior secured debt financing totaling $275 million with Hercules Capital, Inc. acting…
Dyne Therapeutics Secures $275 Million Debt Financing Facility

























